Alzheimer's disease (AD) remains a foremost challenge in neurodegenerative research, with cholinesterase inhibition representing a pivotal mechanism in symptomatic treatment. Inhibitors of ...

Acetylcholinesterase (AChE) is traditionally known for its role in terminating neurotransmission by hydrolysing acetylcholine at synaptic junctions. However, a growing body of research reveals that ...